Understanding patient preferences for screening tests for Barrett's esophagus and esophageal cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather insights into patient preferences regarding screening for Barrett's esophagus and esophageal cancer. Through a multicenter discrete choice-based conjoint survey, patients will evaluate various screening test attributes, including sensitivity, convenience, procedural discomfort, and financial implications. The findings will help identify barriers and preferences that could inform modifications to current screening practices in the United States, ultimately aiming to reduce esophageal cancer mortality rates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Provision to sign and date the consent form.
* Stated willingness to comply with all study procedures and be available for the duration of the study.
* Individual has 3 or more established risk factors for BE (age \> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC).

Exclusion Criteria:

* Unable to consent.
* Prior diagnosis of BE/EAC.
* Life limiting comorbidity/ disability.
* Active dementia/ cognitive impairment.
* Incarcerated.

Where it's running

• University of Colorado Anschutz Medical Campus
  Aurora, Colorado, United States Recruiting

Study contacts

• Principal investigator: Sachin Wani, MD — University of Colorado, Denver
• Study coordinator: Alexa DeBord, MS
• Email: alexa.debord@cuanschutz.edu
• Phone: 303-724-0432

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predictors of symptom improvement after laparoscopic fundoplication

  This study tests what preoperative factors help predict which GERD patients will feel better after laparoscopic fundoplication.

  Recruiting Minia University · Minya, Minya Governorate · NCT07809620

• Potassium-Competitive Acid Blockers in Barrett’s Esophagus on PPI Therapy

  This study tests whether vonoprazan, a potassium-competitive acid blocker, can better reduce acid reflux in adults with nondysplastic Barrett’s esophagus who are already taking a daily PPI.

  Recruiting Phase 4 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07788742

• How radiofrequency ablation affects esophagus stretchiness and mucosal impedance

  This study will test whether radiofrequency ablation changes how stretchy the esophagus is and the mucosal impedance in adults treated for dysplastic Barrett's esophagus.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07126535

• Detecting Barrett's Esophagus with a Non-Endoscopic Device

  This study is testing a new capsule device that collects cells from the esophagus to see if it can effectively detect Barrett's Esophagus in people at high risk, without needing an endoscopy.

  Recruiting Cyted Health Inc · Cordova, Tennessee · NCT06803927

• Stopping routine endoscopic surveillance for low-risk Barrett's esophagus (BLISS Project)

  This project will try stopping routine endoscopies in people with low-risk, non-dysplastic Barrett's esophagus to see if it remains safe.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06803147

• Non-endoscopic test to find Barrett's esophagus in veterans without chronic reflux.

  This project will test whether a simple, non-endoscopic swab-like test can find Barrett's esophagus in veterans over 40 who have risk factors for esophageal cancer but no chronic heartburn.

  Recruiting Louis Stokes VA Medical Center · Cleveland, Ohio · NCT06746623

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.